Literature DB >> 19275067

Diagnosis and treatment of streptococcal pharyngitis.

Beth A Choby1.   

Abstract

Common signs and symptoms of streptococcal pharyngitis include sore throat, temperature greater than 100.4 degrees F (38 degrees C), tonsillar exudates, and cervical adenopathy. Cough, coryza, and diarrhea are more common with viral pharyngitis. Available diagnostic tests include throat culture and rapid antigen detection testing. Throat culture is considered the diagnostic standard, although the sensitivity and specificity of rapid antigen detection testing have improved significantly. The modified Centor score can be used to help physicians decide which patients need no testing, throat culture/rapid antigen detection testing, or empiric antibiotic therapy. Penicillin (10 days of oral therapy or one injection of intramuscular benzathine penicillin) is the treatment of choice because of cost, narrow spectrum of activity, and effectiveness. Amoxicillin is equally effective and more palatable. Erythromycin and first-generation cephalosporins are options in patients with penicillin allergy. Increased group A beta-hemolytic streptococcus (GABHS) treatment failure with penicillin has been reported. Although current guidelines recommend first-generation cephalosporins for persons with penicillin allergy, some advocate the use of cephalosporins in all nonallergic patients because of better GABHS eradication and effectiveness against chronic GABHS carriage. Chronic GABHS colonization is common despite appropriate use of antibiotic therapy. Chronic carriers are at low risk of transmitting disease or developing invasive GABHS infections, and there is generally no need to treat carriers. Whether tonsillectomy or adenoidectomy decreases the incidence of GABHS pharyngitis is poorly understood. At this time, the benefits are too small to outweigh the associated costs and surgical risks.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275067

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  47 in total

1.  Retrospective study of group A Streptococcus oropharyngeal infection diagnosis using a rapid antigenic detection test in a paediatric population from the central region of Portugal.

Authors:  Nuno Mendes; Carmo Miguéis; Jorge Lindo; Teresa Gonçalves; António Miguéis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-01-15       Impact factor: 3.267

2.  Antimicrobial susceptibility of bacterial isolates from patients presenting with ear, nose and throat (ENT) infections in the German community healthcare setting.

Authors:  B Olzowy; M Kresken; M Havel; D Hafner; B Körber-Irrgang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-20       Impact factor: 3.267

3.  Molecular and clinical diagnosis of group A streptococcal pharyngitis in children.

Authors:  Susanna Felsenstein; Diala Faddoul; Richard Sposto; Kristine Batoon; Claudia M Polanco; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

Review 4.  Molecular insight into invasive group A streptococcal disease.

Authors:  Jason N Cole; Timothy C Barnett; Victor Nizet; Mark J Walker
Journal:  Nat Rev Microbiol       Date:  2011-09-16       Impact factor: 60.633

Review 5.  Microbial volatile compounds in health and disease conditions.

Authors:  Robin Michael Statham Thorn; John Greenman
Journal:  J Breath Res       Date:  2012-05-04       Impact factor: 3.262

Review 6.  Update on the management of acute pharyngitis in children.

Authors:  Marta Regoli; Elena Chiappini; Francesca Bonsignori; Luisa Galli; Maurizio de Martino
Journal:  Ital J Pediatr       Date:  2011-01-31       Impact factor: 2.638

7.  The effectiveness of the McIsaac clinical decision rule in the management of sore throat: an evaluation from a pediatrics ward.

Authors:  Saravanapriya Thillaivanam; Arwa M Amin; Sheila Gopalakrishnan; Baharudin Ibrahim
Journal:  Pediatr Res       Date:  2016-05-24       Impact factor: 3.756

8.  Risks and benefits associated with antibiotic use for acute respiratory infections: a cohort study.

Authors:  Sharon B Meropol; A Russell Localio; Joshua P Metlay
Journal:  Ann Fam Med       Date:  2013 Mar-Apr       Impact factor: 5.166

9.  Detection of group a streptococcal pharyngitis by quantitative PCR.

Authors:  Eileen M Dunne; Julia L Marshall; Ciara A Baker; Jayne Manning; Gena Gonis; Margaret H Danchin; Pierre R Smeesters; Catherine Satzke; Andrew C Steer
Journal:  BMC Infect Dis       Date:  2013-07-11       Impact factor: 3.090

Review 10.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.